Higher levy on drug promotion spending (19-39% scale) and on medical device manufacturers (10%)
Article 73 of Act No. 2004-810 of 13 August 2004 on health insurance raises the rates of the scale of the levy on pharmaceutical companies' promotion spending (Article L. 245-2 of the Social Security Code) from 16, 21, 27 and 32% to 19, 29, 36 and 39%, and raises the allowance from €1.5 million to €2.5 million. It doubles the rate of the levy on promotion spending by medical device manufacturers and distributors (Article L. 245-5-2) from 5% to 10%. These rules apply for the first time to the levy due by 1 December 2005.
Measure originators
No official estimate found for this measure.
Measure impact
Drug companies and medical device makers pay a higher levy on their promotion spending from the December 2005 deadline.
Official references
Sources
Procedure timeline
Follow the progress of this fiscal measure through the different stages of the parliamentary procedure.
Administrative implementation
Entrée en vigueur de la mesure et mise en œuvre par l'administration
President of the Republic signature
Publication au Journal officiel
Possible referral to Constitutional Council
Décision de conformité / censure partielle
National Assembly has the final say
Si échec CMP